Neurodegenerative Diseases: current treatment algorithm and potential investment opportunities covered in a lates research report

This report examines the entire neurodegenerative disease therapy area, with a particular focus on the three most prevalent neurodegenerative disorders: Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS).

Pune, India - March 14, 2018 /MarketersMedia/ —

AD and PD represent the most pressing challenges within the disease cluster, due to rapidly increasing prevalence driven by aging populations. Both AD and PD remain ineffectively treated despite substantial investment into R&D by pharmaceutical companies, due to high clinical trial failure rates. As a result there are no disease-modifying therapies for these two indications, with available treatments able to provide only marginal symptomatic relief. MS, the autoimmune disease of the CNS, contrasts with the rest of this cluster, as it affects a different population demographic, and has a lucrative pharmacological market following breakthrough success in the past decade.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options.
• Identify leading products and key unmet needs within the market.
• Recognize innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using proprietary matrix assessments, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Individual matrix assessments are provided for targets categorized into four major classes: protein misfolding, neuromodulators, immunomodulators and neuroprotectants. The most promising first-in-class targets are reviewed in greater detail.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935553
Scope
• Unmet need is extremely high in AD and PD, with MS showing continued promise in the development of effective therapies
• What are the most important etiological risk factors and pathophysiological processes implicated in AD, PD and MS?
• What is the current treatment algorithm?
• How effective are current therapies for these indications, and how does this impact prognosis?
• The AD pipeline is large and contains a very high proportion of first-in-class product innovation.
• Which molecule types and molecular targets are most prominent across AD, PD and MS?
• What are the connections, in terms of first-in-class innovation, between AD, PD and MS?
• Which first-in-class targets are most promising?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935553

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/neurodegenerative-diseases-current-treatment-algorithm-and-potential-investment-opportunities-covered-in-a-lates-research-report/314330

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd%20

Source: MarketersMedia

Release ID: 314330

More Press Releases

Global stocks tumble after new Trump tariff threat

Jun 19, 2018

BEIJING — Global stock markets fell Tuesday after U.S. President Donald Trump escalated a dispute with China over technology policy by threatening a tariff hike on an additional $200 billion of Chinese goods. KEEPING SCORE: Germany's DAX was down a sharp 1.3 percent to 12,673 and France's CAC 40 fell 1.1 percent to 5,394. London's FTSE 100 lost 0.4 percent to 7,598. Wall Street looked poised for heavy losses, with the future for the Dow Jones industrial average off 1.3 percent and that for the Standard & Poor's 500 index down 1.1 percent. ASIA'S DAY: The losses were even heavier...

Asian stocks tumble after new Trump tariff threat

Jun 19, 2018

BEIJING — Asian stocks tumbled Tuesday after U.S. President Donald Trump escalated a dispute with Beijing over technology policy by threatening a tariff hike on additional Chinese goods. KEEPING SCORE: The Shanghai Composite Index fell 2.3 percent to 2,953.54 points and Hong Kong's Hang Seng lost 2 percent to 29,685.28. Tokyo's Nikkei 225 retreated 0.9 percent to 22,482.89 and Seoul's Kospi lost 0.8 percent to 2,356.57. Markets in Taiwan, New Zealand and Southeast Asia also declined. Sydney's S&P-ASX 200 gained 0.3 percent to 6,123.00. TRADE TENSIONS: Trump directed the U.S. Trade Representative to prepare new tariffs on $200 billion in...

Markets Right Now: Stocks look to recover from early skid

Jun 19, 2018

NEW YORK — The latest on developments in financial markets (all times local): 4:00 p.m. Stocks are closing mixed Monday after recovering from early losses. Energy stocks helped the comeback. Chevron gained 1.5 percent, getting a boost from a 1.2 percent rise in the price of U.S. crude oil. Some big technology shares also posted gains. Alphabet, the parent company of Google, rose 2.1 percent. Smaller and more U.S.-focused companies climbed higher. The Russell 2000 index added 0.5 percent to a record 1,692.45. Health care companies weighed on the market, however. Pharmaceutical and biotechnology companies fell. Household goods companies took...

World stocks slide over trade tensions, German politics

Jun 19, 2018

SINGAPORE — Global stocks dropped Monday on concerns over trade as the U.S. and China scheduled the start of tariffs on each other's goods, and a row over migrants threatened the German government. Markets in China and Hong Kong were closed for a holiday. KEEPING SCORE: Germany's DAX lost 1.3 percent to 12,839 and France's CAC 40 shed 1.2 percent to 5,433. Britain's FTSE 100 dipped 0.4 percent to 7,605. Wall Street was poised to open lower. Dow futures dropped 0.7 percent and the S&P 500 futures were down 0.6 percent. U.S.-CHINA TARIFFS: Tariffs mooted by the world's two biggest...

US stocks and bond yields dip amid trade worries

Jun 19, 2018

NEW YORK — U.S. stocks closed out a whirlwind week with a modest loss Friday as markets gauged how much to fret about the Trump administration's decision to step up the trade dispute between the world's two biggest economies. The White House announced tariffs on $50 billion of imports from China, and China's almost-immediate response was a promise to retaliate with its own of the same scale. Stocks sank from the start of trading, and the S&P 500 was down 0.7 percent at one point before paring its loss as the day progressed. At the close, the S&P 500 was...

Subscribe to our newsletter!

Your Name

Your Email Address